Ali T Taher (Ali Taher)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 69

Top Topics

Sickle Cell Disease

Venous Thromboembolism

Top Venues

American journal of hematology

Expert review of hematology

Annals of hematology

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Khaled M Musallam, Sujit Sheth, Maria Domenica Cappellini, Gian Luca Forni, Aurelio Maggio, Ali T Taher
Anemia and iron overload as prognostic markers of outcomes in β-thalassemia. Expert review of hematology 17 (9) (2024)
Gian Luca Forni, Antonis Kattamis, Kevin H M Kuo, Aurelio Maggio, Sujit Sheth, Ali T Taher, Vip Viprakasit
Iron chelation therapy for children with transfusion-dependent β-thalassemia: How young is too young? Pediatric blood & cancer 71 (8) (2024)
Khaled M Musallam, Sujit Sheth, Maria Domenica Cappellini, Gian Luca Forni, Aurelio Maggio, Ali T Taher
Anemia and iron overload as prognostic markers of outcomes in β-thalassemia. Expert review of hematology (2024)
Gian Luca Forni, Antonis Kattamis, Kevin H M Kuo, Aurelio Maggio, Sujit Sheth, Ali T Taher, Vip Viprakasit
Iron chelation therapy for children with transfusion-dependent β-thalassemia: How young is too young? Pediatric blood & cancer (2024)
Ali T Taher, Khaled M Musallam, Vip Viprakasit, Antonis Kattamis, Jennifer Lord-Bessen, Aylin Yucel, Shien Guo, Christopher G Pelligra, Alan L Shields, Jeevan K Shetty, Dimana Miteva, Luciana Moro Bueno, Maria Domenica Cappellini
Psychometric evaluation of the NTDT-PRO questionnaire for assessing symptoms in patients with non-transfusion-dependent beta-thalassaemia. BMJ open 13 (3) (2023)
Peter Hokland, Shahina Daar, Wael Khair, Sujit Sheth, Ali T Taher, Lorenza Torti, Chattree Hantaweepant, Deborah Rund
Thalassaemia-A global view. British journal of haematology (2023)
Khaled M Musallam, Ali T Taher, Antonios Kattamis, Kevin H M Kuo, Sujit Sheth, Maria Domenica Cappellini
Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy. Drug design, development and therapy 17 (2023)
Maria Domenica Cappellini, Ali T Taher, Antonio Piga, Farrukh Shah, Ersi Voskaridou, Vip Viprakasit, John B Porter, Olivier Hermine, Ellis J Neufeld, Alexis A Thompson, Derek Tang, Aylin Yucel, Jennifer Lord-Bessen, Peiwen Yu, Shien Guo, Jeevan K Shetty, Dimana Miteva, Tatiana Zinger, Jay T Backstrom, Esther Natalie Oliva
Health-related quality of life in patients with β-thalassemia: Data from the phase 3 BELIEVE trial of luspatercept. European journal of haematology (2023)
Ali T Taher, Khaled M Musallam, Vip Viprakasit, Antonis Kattamis, Jennifer Lord-Bessen, Aylin Yucel, Shien Guo, Christopher G Pelligra, Alan L Shields, Jeevan K Shetty, Dimana Miteva, Luciana Moro Bueno, Maria Domenica Cappellini
Psychometric evaluation of the NTDT-PRO questionnaire for assessing symptoms in patients with non-transfusion-dependent beta-thalassaemia. BMJ open 13 (3) (2023)
Maria Domenica Cappellini, Ali T Taher, Antonio Piga, Farrukh Shah, Ersi Voskaridou, Vip Viprakasit, John B Porter, Olivier Hermine, Ellis J Neufeld, Alexis A Thompson, Derek Tang, Aylin Yucel, Jennifer Lord-Bessen, Peiwen Yu, Shien Guo, Jeevan K Shetty, Dimana Miteva, Tatiana Zinger, Jay T Backstrom, Esther Natalie Oliva
Health-related quality of life in patients with β-thalassemia: Data from the phase 3 BELIEVE trial of luspatercept. European journal of haematology (2023)
Vip Viprakasit, Mona M Hamdy, Hoda M A Hassab, Laila M Sherief, Muneer Al-Bagshi, Mohammed Khattab, Suporn Chuncharunee, Phu Chi Dung, Alphan Küpesiz, Ankita Shekhawat, Yamini Sonawane, Laura Torres Perez, Cassandra Slader, Ali T Taher
Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia. Annals of hematology (2023)
Hassan Fawaz, Mohammad Hassan Hodroj, Hawraa Tarhini, Chirine O Trad, Ali T Taher
Alemtuzumab induced acquired hemophilia A in multiple sclerosis: a case report. Annals of hematology (2023)
Sujit Sheth, Ali T Taher, Thomas D Coates, Antonios Kattamis, Maria Domenica Cappellini
Management of luspatercept therapy in patients with transfusion-dependent β-thalassaemia. British journal of haematology (2023)
Khaled M Musallam, Louise Lombard, Kristin D Kistler, Maria Arregui, Keely S Gilroy, Christina Chamberlain, Erin Zagadailov, Kimberly Ruiz, Ali T Taher
Epidemiology of clinically significant forms of alpha- and beta-thalassemia: A global map of evidence and gaps. American journal of hematology (2023)
Maria Domenica Cappellini, Ali T Taher, Antonio Piga, Farrukh Shah, Ersi Voskaridou, Vip Viprakasit, John B Porter, Olivier Hermine, Ellis J Neufeld, Alexis A Thompson, Derek Tang, Aylin Yucel, Jennifer Lord-Bessen, Peiwen Yu, Shien Guo, Jeevan K Shetty, Dimana Miteva, Tatiana Zinger, Jay T Backstrom, Esther Natalie Oliva
Health-related quality of life in patients with β-thalassemia: Data from the phase 3 BELIEVE trial of luspatercept. European journal of haematology (2023)
Saad Sabbagh, Kawthar Jarrah, Rayan Bou-Fakhredin, Dana Saadeh, Ali T Taher
Anhidrosis associated with long-term use of hydroxyurea in a patient with myeloproliferative neoplasm. Annals of hematology 101 (7) (2022)
Nour M Moukalled, Rayan Bou-Fakhredin, Ali T Taher
Pregnancy and sickle cell disease: an overview of complications and suggested perinatal care. Expert review of hematology 15 (12) (2022)
Nour M Moukalled, Jana G Hashash, Ali T Taher
Inflammatory Bowel Disease: An Indication to Screen for Thrombophilia? Diseases (Basel, Switzerland) 10 (1) (2022)
Rayan Bou-Fakhredin, Lucia De Franceschi, Irene Motta, Maria Domenica Cappellini, Ali T Taher
Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective. Pharmaceuticals (Basel, Switzerland) 15 (6) (2022)
Khaled M Musallam, Maria Domenica Cappellini, Shahina Daar, Amal El-Beshlawy, Ali T Taher
Magnitude of cumulative iron overload correlates with the severity of anemia in untreated non-transfusion-dependent β-thalassemia. Annals of hematology (2022)
Yong-Rong Lai, Maria Domenica Cappellini, Yesim Aydinok, John Porter, Zeynep Karakas, Vip Viprakasit, Noppadol Siritanaratkul, Antonis Kattamis, Rongrong Liu, Miguel Izquierdo, Janet Lasher, Sameera Govindaraju, Ali T Taher
An open-label, multicenter, efficacy, and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results. American journal of hematology 97 (8) (2022)
Rayan Bou-Fakhredin, Lucia De Franceschi, Irene Motta, Assaad A Eid, Ali T Taher, Maria Domenica Cappellini
Redox Balance in β-Thalassemia and Sickle Cell Disease: A Love and Hate Relationship. Antioxidants (Basel, Switzerland) 11 (5) (2022)
Ali Atoui, Kawthar Jarrah, Layal Al Mahmasani, Rayan Bou-Fakhredin, Ali T Taher
Deep venous thrombosis and pulmonary embolism after COVID-19 mRNA vaccination. Annals of hematology 101 (5) (2022)
Yasser Wali, Tamer Hassan, Pimlak Charoenkwan, Sara Trompeter, Immacolata Tartaglione, Raffaella Origa, Maria Rita Gamberini, Vip Viprakasit, Miguel Izquierdo, Socrates Opio, Tania Roy, Ali T Taher
Crushed deferasirox film-coated tablets in pediatric patients with transfusional hemosiderosis: Results from a single-arm, interventional phase 4 study (MIMAS). American journal of hematology 97 (8) (2022)
Khaled M Musallam, Angela Vitrano, Antonella Meloni, Sebastiano Addario Pollina, Vito Di Marco, Saqib Hussain Ansari, Aldo Filosa, Paolo Ricchi, Adriana Ceci, Shahina Daar, Efthymia Vlachaki, Sylvia T Singer, Zaki A Naserullah, Alessia Pepe, Salvatore Scondotto, Gabriella Dardanoni, Mehran Karimi, Amal El-Beshlawy, Mahmoud Hajipour, Fedele Bonifazi, Elliott Vichinsky, Ali T Taher, Vijay G Sankaran, Aurelio Maggio, null null
Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemia. British journal of haematology (2021)
Rayan Bou-Fakhredin, Batoul Dia, Hilda E Ghadieh, Stefano Rivella, Maria Domenica Cappellini, Assaad A Eid, Ali T Taher
CYP450 Mediates Reactive Oxygen Species Production in a Mouse Model of β-Thalassemia through an Increase in 20-HETE Activity. International journal of molecular sciences 22 (3) (2021)
Sally Temraz, Nour Moukalled, Grigorios T Gerotziafas, Ismail Elalamy, Luis Jara Palomares, Maya Charafeddine, Ali T Taher
Association between Radiotherapy and Risk of Cancer Associated Venous Thromboembolism: A Sub-Analysis of the COMPASS-CAT Study. Cancers 13 (5) (2021)
Achille Iolascon, Paola Bianchi, Immacolata Andolfo, Roberta Russo, Wilma Barcellini, Elisa Fermo, Gergely Toldi, Stefano Ghirardello, Davis Rees, Richard Van Wijk, Antonis Kattamis, Patrick G Gallagher, Noemi Roy, Ali T Taher, Razan Mohty, Andreas Kulozik, Lucia De Franceschi, Antonella Gambale, Mariane De Montalembert, Gian Luca Forni, Cornelis L Harteveld, Josef Prchal, null null
Recommendations for diagnosis and treatment of methemoglobinemia. American journal of hematology 96 (12) (2021)
Charbel F Matar, Rayan Bou-Fakhredin, Roberta Russo, Immacolata Andolfo, Achille Iolascon, Ali T Taher
Recommendations for pregnancy in Fanconi anemia. Expert opinion on biological therapy 21 (11) (2021)
John B Porter, Ali T Taher, Vip Viprakasit, Antonios Kattamis, Thomas D Coates, Maciej W Garbowski, Franz Dürrenberger, Vania Manolova, Frank Richard, Maria Domenica Cappellini
Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development. Expert review of hematology 14 (7) (2021)
Farah Abdulhai, Miran A Jaffa, Joseph Elias, Patrick Zakka, Mostafa Hotait, Rayan Bou-Fakhredin, Samir Arnaout, Ali T Taher, Marwan M Refaat
Digital thermography and vascular involvement in β-thalassemia intermedia. Annals of hematology 100 (10) (2021)
Antoine N Saliba, Ali T Taher
The Lebanese healthcare sector: The point of exsanguination. American journal of hematology 96 (11) (2021)
Ali T Taher, Maria Domenica Cappellini
Luspatercept for β-thalassemia: beyond red blood cell transfusions. Expert opinion on biological therapy 21 (11) (2021)
Khaled M Musallam, Angela Vitrano, Antonella Meloni, Sebastiano Addario Pollina, Mehran Karimi, Amal El-Beshlawy, Mahmoud Hajipour, Vito Di Marco, Saqib Hussain Ansari, Aldo Filosa, Paolo Ricchi, Adriana Ceci, Shahina Daar, Efthymia Vlachaki, Sylvia Titi Singer, Zaki A Naserullah, Alessia Pepe, Salvatore Scondotto, Gabriella Dardanoni, Fedele Bonifazi, Vijay G Sankaran, Elliott Vichinsky, Ali T Taher, Aurelio Maggio, null null
Risk of mortality from anemia and iron overload in nontransfusion-dependent β-thalassemia. American journal of hematology (2021)
Khaled M Musallam, Rayan Bou-Fakhredin, Maria Domenica Cappellini, Ali T Taher
2021 update on clinical trials in β-thalassemia. American journal of hematology 96 (11) (2021)
Ali T Taher, Rayan Bou-Fakhredin, Antonios Kattamis, Vip Viprakasit, Maria Domenica Cappellini
Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategies. Expert review of hematology 14 (10) (2021)
Ali T Taher, Layal Al Mahmasani, Abdallah Aadra, Patricia Yazbeck, Georges Abi Saad, Fadi Nasr, Rita Habib, Amal Chalfoun, Fadi Haddad
Assessment of Lebanese healthcare professionals' awareness on acquired haemophilia: a cross-sectional study. Hematology (Amsterdam, Netherlands) 26 (1) (2021)
Ali T Taher, Vip Viprakasit, Maria Domenica Cappellini, Dominik Kraus, Patrick Cech, Dietmar Volz, Erica Winter, Stephane Nave, Juergen Dukart, Omar Khwaja, Annette Koerner, Ricardo Hermosilla, Carlo Brugnara
Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non-transfusion-dependent β-thalassaemia. British journal of haematology 194 (2) (2021)
Georges El Hasbani, Ali T Taher, Savinio Sciascia, Imad Uthman
Antiphospholipid syndrome: the need for new international classification criteria. Expert review of clinical immunology 17 (4) (2021)
Rayan Bou-Fakhredin, Hisham Daadaa, Suzanne Koussa, Therese Abou Nasr, Peter Noun, Ali T Taher
SARS-CoV-2 infection in patients with β-thalassemia: Experience from Lebanon. American journal of hematology 96 (8) (2021)
Khaled M Musallam, Maria Domenica Cappellini, Vip Viprakasit, Antonis Kattamis, Stefano Rivella, Ali T Taher
Revisiting the non-transfusion-dependent (NTDT) vs. transfusion-dependent (TDT) thalassemia classification 10 years later. American journal of hematology 96 (2) (2020)
Antoine N Saliba, Ali T Taher
A land in agony: COVID-19, economic collapse, political corruption, and a deadly blast. American journal of hematology 96 (1) (2020)
Ali T Taher, Rayan Bou-Fakhredin, Firas Kreidieh, Irene Motta, Lucia De Franceschi, Maria Domenica Cappellini
Care of patients with hemoglobin disorders during the COVID-19 pandemic: An overview of recommendations. American journal of hematology 95 (8) (2020)
Rayan Bou-Fakhredin, Nadim N Ghanem, Firas Kreidieh, Rami Tabbikha, Hisham Daadaa, Josephine Ajouz, Suzanne Koussa, Ali T Taher
A Report on the Education, Employment and Marital Status of Thalassemia Patients from a Tertiary Care Center in the Middle East. Hemoglobin 44 (4) (2020)
Khaled M Musallam, Stefano Rivella, Ali T Taher
Management of non-transfusion-dependent β-thalassemia (NTDT): The next 5 years. American journal of hematology 96 (3) (2020)
Rayan Bou-Fakhredin, Rami Tabbikha, Hisham Daadaa, Ali T Taher
Emerging therapies in β-thalassemia: toward a new era in management. Expert opinion on emerging drugs 25 (2) (2020)
Peter Noun, Ahmad Ibrahim, Mohammad Hassan Hodroj, Rayan Bou-Fakhredin, Ali T Taher
COVID-19 in benign hematology: emerging challenges and special considerations for healthcare professionals. Expert review of hematology 13 (10) (2020)
Mohamed A Yassin, Ali T Taher, Vikram Mathews, Hsin-An Hou, Tahir Shamsi, Tülin Firatli Tuğlular, Zhijian Xiao, Soo-Jeong Kim, Wu Depei, Junmin Li, Gerd Rippin, Islam Sadek, Asif Siddiqui, Raymond Siu Ming Wong
MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria. Cancer medicine 9 (13) (2020)
Maria Domenica Cappellini, Antonis Kattamis, Vip Viprakasit, Pranee Sutcharitchan, Joseph Pariseau, Abderrahmane Laadem, Valerie Jessent-Ciaravino, Ali T Taher
Quality of life in patients with β-thalassemia: A prospective study of transfusion-dependent and non-transfusion-dependent patients in Greece, Italy, Lebanon, and Thailand. American journal of hematology 94 (10) (2019)
Ali T Taher, Raffaella Origa, Silverio Perrotta, Alexandra Kouraklis, Khawla Belhoul, Vicky Huang, Jackie Han, Andreas Bruederle, Priyanka Bobbili, Mei Sheng Duh, John B Porter
Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis. American journal of hematology 94 (4) (2019)
Amal A Gharamti, Nour M Moukalled, Ali T Taher, Zeina A Kanafani
Recurrent Campylobacter Bacteremia as the First Manifestation of Hypogammaglobulinemia: a Case Report and Literature Review. Infection & chemotherapy 52 (3) (2019)
Ali T Taher, Maria Domenica Cappellini, Khaled M Musallam
Development of a thalassemia-related thrombosis risk scoring system. American journal of hematology 94 (8) (2019)
Antoine N Saliba, Hani Tamim, Aurelie Mailhac, Faek R Jamali, Ali T Taher
Disparities in the risk of septic events in patients undergoing splenectomy for hematological malignancies (D-ROSE-PUSH): A study based on ACS-NSQIP database. American journal of hematology 94 (8) (2019)
Vip Viprakasit, Amr Ajlan, Yesim Aydinok, Basim A A Al Ebadi, Hany Dewedar, Ahmed S Ibrahim, Lamis Ragab, Omar Trad, Ahmed S Wataify, Lily L L Wong, Ali T Taher
MRI for the diagnosis of cardiac and liver iron overload in patients with transfusion-dependent thalassemia: An algorithm to guide clinical use when availability is limited. American journal of hematology 93 (6) (2018)
Ali T Taher, Maria Domenica Cappellini, Vip Viprakasit, Pranee Sutcharitchan, Dalia Mahmoud, Abderrahmane Laadem, Anzalee Khan, Chad Gwaltney, Gale Harding, Kenneth Attie, Xiaosha Zhang, Jun Zou, Joseph Pariseau, X Henry Hu, Antonis Kattamis
Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO© ). American journal of hematology 94 (2) (2018)
Ali T Taher, Vip Viprakasit, Maria Domenica Cappellini, Pranee Sutcharitchan, Richard Ward, Dalia Mahmoud, Abderrahmane Laadem, Anzalee Khan, Chad Gwaltney, Gale Harding, Kenneth Attie, Xiaosha Zhang, Jun Zou, Joseph Pariseau, X Henry Hu, Antonis Kattamis
Development of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO© ). American journal of hematology 94 (2) (2018)
Antoine N Saliba, Hassan Moukhadder, Hassan Beydoun, Afif Harb, Rania Farhat, Hussein Abou Ghaddara, Ali T Taher
Assessment and study of knowledge and practice across different settings in Lebanon based on the recommendations of the American Society of Hematology Choosing Wisely campaign (ASK-PADS study). American journal of hematology 93 (11) (2018)
Antonios Kattamis, Yesim Aydinok, Ali T Taher
Optimising management of deferasirox therapy for patients with transfusion-dependent thalassaemia and lower-risk myelodysplastic syndromes. European journal of haematology 101 (3) (2018)
Ali T Taher, Sebastian Weber, Jackie Han, Andreas Bruederle, John B Porter
Predicting serum ferritin levels in patients with iron overload treated with the film-coated tablet of deferasirox during the ECLIPSE study. American journal of hematology 94 (1) (2018)
Ala I Sharara, Luma Basma O Rustom, Majd Marrache, Hussein H Rimmani, Halim Bou Daher, Suzanne Koussa, Ali T Taher
Sofosbuvir/velpatasvir for chronic hepatitis C infection in patients with transfusion-dependent thalassemia. American journal of hematology 94 (2) (2018)
Ali T Taher, Raffaella Origa, Silverio Perrotta, Alexandra Kourakli, Giovan Battista Ruffo, Antonis Kattamis, Ai-Sim Goh, Annelore Cortoos, Vicky Huang, Marine Weill, Raquel Merino Herranz, John B Porter
New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, phase II ECLIPSE study. American journal of hematology 92 (5) (2017)
Joseph E Roumi, Hassan M Moukhadder, Giovanna Graziadei, Martina Pennisi, Maria Domenica Cappellini, Ali T Taher
Pregnancy in β-thalassemia intermedia at two tertiary care centers in Lebanon and Italy: A follow-up report on fetal and maternal outcomes. American journal of hematology 92 (6) (2017)
Racha Halawi, Maria D Cappellini, Ali T Taher
A higher prevalence of hematologic malignancies in patients with thalassemia: Background and culprits. American journal of hematology 92 (5) (2017)
Maria Domenica Cappellini, Josep Comin-Colet, Angel de Francisco, Axel Dignass, Wolfram Doehner, Carolyn S Lam, Iain C Macdougall, Gerhard Rogler, Clara Camaschella, Rezan Kadir, Nicholas J Kassebaum, Donat R Spahn, Ali T Taher, Khaled M Musallam, null null
Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. American journal of hematology 92 (10) (2017)
Ali T Taher, Antoine N Saliba, Kevin H M Kuo, Patricia J Giardina, Alan R Cohen, Ellis J Neufeld, Yesim Aydinok, Janet L Kwiatkowski, Brenda I Jeglinski, Keith Pietropaolo, Gregory Berk, Vip Viprakasit
Safety and pharmacokinetics of the oral iron chelator SP-420 in β-thalassemia. American journal of hematology 92 (12) (2017)
Antoine N Saliba, Khaled M Musallam, Maria D Cappellini, Giovanna Graziadei, Shahina Daar, Vip Viprakasit, Ali T Taher
Serum ferritin values between 300 and 800 ng/mL in nontransfusion-dependent thalassemia: A probability curve to guide clinical decision making when MRI is unavailable. American journal of hematology 92 (3) (2017)
Ali T Taher, Zeynep Karakas, Elena Cassinerio, Noppadol Siritanaratkul, Antonis Kattamis, Aurelio Maggio, Stefano Rivella, Norbert Hollaender, Bruyère Mahuzier, Brian Gadbaw, Yesim Aydinok
Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study. Blood 131 (2) (2017)
Racha Halawi, Hassan Beydoun, M Domenica Cappellini, Valeria Ferla, Ali T Taher
Hematologic malignancies in thalassemia: Adding new cases to the repertoire. American journal of hematology 92 (5) (2017)
Antoine N Saliba, Hassan M Moukhadder, Afif Harb, Hassan Beydoun, Rayan Bou-Fakhredin, Ali T Taher
Causes of hospital admission in β-thalassemia (CHAT) in Lebanon from 1995 to 2015: A pilot retrospective study from a tertiary care center. American journal of hematology 92 (12) (2017)